Sugar (Glucose) Fasting

Diabetes

Report in 4Hrs

At Home

Fasting Required

Details

Measures blood sugar levels to diagnose diabetes

₹29₹70

59% OFF

FREE:

Ai Insights

Sugar (Glucose) Fasting Test - Comprehensive Medical Information Guide

Section 1: Why is it done?
- Test Measurement: Measures the amount of glucose (blood sugar) in the bloodstream after a period of fasting, typically 8-12 hours without food or drink
- Screening for Diabetes: Primary screening test for Type 2 diabetes and prediabetes in asymptomatic individuals
- Monitoring Existing Diabetes: Routine monitoring in patients with known diabetes to assess glycemic control and treatment effectiveness
- Risk Assessment: Evaluates metabolic health in patients with risk factors (obesity, family history, sedentary lifestyle, hypertension)
- Diagnostic Confirmation: Used to confirm diagnosis when patients present with symptoms of hyperglycemia (excessive thirst, frequent urination, fatigue)
- Routine Physical Examinations: Standard component of annual health checkups, particularly in adults over 45 years of age or those with multiple risk factors
- Preoperative Assessment: Baseline measurement before surgical procedures to identify perioperative glucose management needs
Section 2: Normal Range
- Normal Fasting Glucose: 70-99 mg/dL (3.9-5.5 mmol/L) in non-diabetic adults
- Prediabetic Range: 100-125 mg/dL (5.6-6.9 mmol/L) indicates impaired fasting glucose
- Diabetic Range: ≥126 mg/dL (≥7.0 mmol/L) on two separate occasions suggests Type 2 diabetes diagnosis
- Hypoglycemic Range: <70 mg/dL (<3.9 mmol/L) indicates low blood glucose requiring immediate intervention
- Units of Measurement: Measured in milligrams per deciliter (mg/dL) in the United States or millimoles per liter (mmol/L) in most other countries
- Special Considerations: Children and adolescents may have slightly different reference ranges; pregnant women use different criteria (gestational diabetes screening); elderly patients may have higher normal values
Section 3: Interpretation
- 70-99 mg/dL (Normal): Healthy fasting glucose level indicating normal glucose metabolism and pancreatic beta cell function; no diabetes diagnosis
- 100-125 mg/dL (Prediabetes/Impaired Fasting Glucose): Indicates glucose metabolism is abnormal but not yet at diabetic levels; individual has significantly increased risk of developing Type 2 diabetes; lifestyle modifications and repeat testing recommended within 3-6 months
- ≥126 mg/dL on Two Separate Tests (Diabetes): Diagnostic criterion for Type 2 diabetes mellitus; indicates significant impairment of glucose homeostasis; requires medical treatment and close monitoring
- <70 mg/dL (Hypoglycemia): Low blood glucose requiring immediate evaluation; may cause symptoms (tremor, sweating, confusion, loss of consciousness); investigate cause including medication side effects, inadequate caloric intake, or insulinoma
- Factors Affecting Results: Stress, illness, infection, medications (corticosteroids, stimulants), recent surgery, inadequate fasting, time of day variations, hemolysis during collection
- Clinical Significance: More specific than random glucose testing due to standardized fasting conditions; reflects hepatic glucose production; lower inter-individual variability; used as foundation for diabetes diagnosis and cardiovascular risk assessment
- Borderline Values: Results at cutoff values (100, 126 mg/dL) warrant repeat testing; consider HbA1c or glucose tolerance test for confirmation; serial monitoring recommended to identify trends
Section 4: Associated Organs
- Primary Organ - Pancreas: Beta cells produce insulin; dysregulation results in impaired glucose regulation; chronic hyperglycemia damages pancreatic function (secondary diabetes)
- Liver: Primary site of glucose synthesis (gluconeogenesis) during fasting; controls glucose output; fatty liver disease associated with insulin resistance
- Kidneys: Filter glucose when levels exceed renal threshold (usually >180 mg/dL); chronic hyperglycemia causes diabetic nephropathy and kidney disease
- Associated Diseases - Type 2 Diabetes Mellitus: Progressive disease of insulin resistance; major cause of morbidity and mortality; affects multiple organ systems
- Associated Diseases - Prediabetes: Increased risk of cardiovascular disease, metabolic syndrome, and progression to overt diabetes; approximately 15-30% of prediabetics develop diabetes within 5 years
- Complications of Hyperglycemia: Microvascular - retinopathy (vision loss), nephropathy (kidney failure), neuropathy (nerve damage); Macrovascular - coronary artery disease, cerebrovascular disease, peripheral arterial disease
- Associated Conditions: Metabolic syndrome, obesity, hypertension, dyslipidemia, polycystic ovary syndrome (PCOS), acanthosis nigricans, cushing's syndrome, acromegaly, chronic pancreatitis
- Hypoglycemic Disorders: Insulinoma, excessive alcohol consumption, adrenal insufficiency, growth hormone deficiency, sepsis, malnutrition
Section 5: Follow-up Tests
- HbA1c (Glycated Hemoglobin): Recommended to confirm diagnosis of diabetes; reflects average glucose over 2-3 months; diagnostic criteria ≥6.5% (≥48 mmol/mol); performed with fasting glucose when diabetes suspected
- Oral Glucose Tolerance Test (OGTT): Ordered if fasting glucose is borderline (100-125 mg/dL); patient ingests 75g glucose; blood drawn at baseline and 2-hour; diagnoses diabetes and impaired glucose tolerance; gold standard for gestational diabetes screening
- Random Blood Glucose: Useful for symptomatic patients when fasting not feasible; ≥200 mg/dL with symptoms diagnostic of diabetes; used for quick screening in clinical settings
- Fasting Insulin Level: Assess pancreatic beta cell function and insulin resistance; elevated levels suggest insulin resistance; calculated HOMA-IR index determines degree of resistance
- C-Peptide Level: Evaluates endogenous insulin secretion; helps differentiate Type 1 from Type 2 diabetes; useful when hypoglycemia cause is unclear
- Metabolic Panel: Assess kidney function (creatinine, BUN), liver function (AST, ALT, bilirubin), electrolytes; important in diabetic patients for baseline and monitoring
- Lipid Panel: Measure cholesterol, LDL, HDL, triglycerides; assess cardiovascular risk; typically abnormal in diabetes; baseline and annual monitoring recommended
- Urinalysis and Urine Microalbumin: Screen for diabetic nephropathy and kidney disease; annual screening in all diabetics; microalbumin appears before macroproteinuria
- Thyroid Function Tests (TSH, Free T4): Screen for associated autoimmune thyroid disease; approximately 10-15% of Type 1 diabetics have hypothyroidism
- Continuous Glucose Monitoring (CGM): Advanced monitoring for insulin-dependent diabetics; provides real-time glucose readings and trend data; guides insulin adjustment
- Monitoring Frequency: Prediabetes - repeat testing annually or if lifestyle modifications show adherence; Established diabetes - HbA1c every 3 months (uncontrolled) to annually (controlled); metabolic panel annually; lipid panel annually
Section 6: Fasting Required?
- Fasting Requirement: YES - Fasting is absolutely required for accurate fasting glucose measurement
- Fasting Duration: Minimum 8 hours; standard is 10-12 hours; overnight fasting (8:00 PM to 8:00 AM) is most practical; results are most accurate after 10-hour fasting period
- Dietary Restrictions: No food consumption during fasting period; no milk or dairy products; no juice, soda, or sweetened beverages; plain water is permitted and encouraged; no chewing gum (contains glucose or sugar)
- Medication Instructions: Continue all regular medications unless specifically instructed otherwise by physician; diabetes medications (metformin, sulfonylureas, insulin) should be held until after blood draw to avoid hypoglycemia; notify lab of all medications taken, especially steroids or stimulants that elevate glucose
- Physical Activity: Avoid strenuous exercise 24-30 hours before test; light activity is acceptable; intense exercise affects glucose metabolism and can artificially lower results
- Stress Management: Minimize emotional stress before testing; stress hormones (cortisol, adrenaline) elevate glucose levels; arrive early to appointment for relaxation
- Sleep and Circadian Rhythm: Ensure adequate sleep (7-9 hours) night before test; sleep deprivation elevates fasting glucose; maintain consistent sleep schedule
- Alcohol Avoidance: Avoid alcohol 24-48 hours before test; alcohol consumption affects hepatic glucose production and can cause hypoglycemia or falsely alter results
- Smoking: Avoid smoking 30 minutes before blood draw; nicotine is a sympathomimetic agent that increases glucose and blood pressure
- Timing of Test: Early morning appointment recommended (7-8 AM) to ensure proper overnight fasting; dawn phenomenon (early morning glucose surge) not significant at 8+ hour fasting point
- Patient Identification of Fasting Status: Communicate fasting duration to phlebotomist; non-fasting samples must be clearly labeled as 'non-fasting' or 'random' to prevent misinterpretation; fasting requirement not met invalidates diagnostic interpretation

How our test process works!